ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis
Europe - FRA:LLY - US5324571083 - Common Stock
788.8 EUR
+21.2 (+2.76%)
We assign a fundamental rating of 6 out of 10 to LLY. LLY was compared to 53 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY shows excellent growth, but is valued quite expensive already. This makes LLY very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year LLY was profitable.
LLY had a positive operating cash flow in the past year.
In the past 5 years LLY has always been profitable.
LLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 16.02%, LLY belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
LLY has a better Return On Equity (77.38%) than 96.23% of its industry peers.
Looking at the Return On Invested Capital, with a value of 28.84%, LLY belongs to the top of the industry, outperforming 94.34% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LLY is significantly above the industry average of 14.46%.
The last Return On Invested Capital (28.84%) for LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
The Profit Margin of LLY (30.99%) is better than 96.23% of its industry peers.
In the last couple of years the Profit Margin of LLY has declined.
LLY has a Operating Margin of 44.41%. This is amongst the best in the industry. LLY outperforms 94.34% of its industry peers.
LLY's Operating Margin has improved in the last couple of years.
LLY has a better Gross Margin (83.03%) than 84.91% of its industry peers.
LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LLY is creating value.
LLY has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LLY has less shares outstanding
LLY has a worse debt/assets ratio than last year.
2.2 Solvency
LLY has an Altman-Z score of 7.28. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
LLY has a better Altman-Z score (7.28) than 92.45% of its industry peers.
The Debt to FCF ratio of LLY is 6.60, which is on the high side as it means it would take LLY, 6.60 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LLY (6.60) is worse than 62.26% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
LLY has a Debt to Equity ratio of 1.72. This is in the lower half of the industry: LLY underperforms 79.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 7.28 |
ROIC/WACC3.3
WACC8.74%
2.3 Liquidity
LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
LLY has a Current ratio of 1.55. This is in the better half of the industry: LLY outperforms 64.15% of its industry peers.
LLY has a Quick Ratio of 1.24. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
LLY has a Quick ratio of 1.24. This is in the better half of the industry: LLY outperforms 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
Measured over the past years, LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.41%.
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
LLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.19% yearly.
LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.70% yearly.
EPS Next Y74.46%
EPS Next 2Y52.91%
EPS Next 3Y41.49%
EPS Next 5Y30.19%
Revenue Next Year36.71%
Revenue Next 2Y27.31%
Revenue Next 3Y23.26%
Revenue Next 5Y17.7%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
LLY is valuated quite expensively with a Price/Earnings ratio of 41.30.
Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 62.26% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. LLY is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 29.88, which means the current valuation is very expensive for LLY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 67.92% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.53. LLY is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.3 | ||
| Fwd PE | 29.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LLY is valued a bit more expensive than the industry average as 67.92% of the companies are valued more cheaply.
67.92% of the companies in the same industry are cheaper than LLY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 133.55 | ||
| EV/EBITDA | 30.72 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LLY's earnings are expected to grow with 41.49% in the coming years.
PEG (NY)0.55
PEG (5Y)2.49
EPS Next 2Y52.91%
EPS Next 3Y41.49%
5. Dividend
5.1 Amount
LLY has a yearly dividend return of 0.71%, which is pretty low.
LLY's Dividend Yield is comparable with the industry average which is at 2.99.
Compared to an average S&P500 Dividend Yield of 2.38, LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
5.2 History
On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
The dividend of LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y52.91%
EPS Next 3Y41.49%
FRA:LLY (11/4/2025, 5:26:42 PM)
788.8
+21.2 (+2.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap746.57B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80
Price Target796.51 (0.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
Yearly Dividend4.27
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.54%
Min EPS beat(2)14.51%
Max EPS beat(2)18.57%
EPS beat(4)4
Avg EPS beat(4)12.23%
Min EPS beat(4)6.45%
Max EPS beat(4)18.57%
EPS beat(8)7
Avg EPS beat(8)11.63%
EPS beat(12)10
Avg EPS beat(12)23.44%
EPS beat(16)13
Avg EPS beat(16)17.2%
Revenue beat(2)2
Avg Revenue beat(2)6.69%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.66%
Revenue beat(4)2
Avg Revenue beat(4)2.91%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.66%
Revenue beat(8)4
Avg Revenue beat(8)2.37%
Revenue beat(12)7
Avg Revenue beat(12)2.63%
Revenue beat(16)9
Avg Revenue beat(16)2.03%
PT rev (1m)3.45%
PT rev (3m)-6.28%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)1.07%
EPS NY rev (1m)-1.18%
EPS NY rev (3m)3.8%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.3 | ||
| Fwd PE | 29.88 | ||
| P/S | 14.47 | ||
| P/FCF | 133.55 | ||
| P/OCF | 53.52 | ||
| P/B | 36.13 | ||
| P/tB | 75.08 | ||
| EV/EBITDA | 30.72 |
EPS(TTM)19.1
EY2.42%
EPS(NY)26.4
Fwd EY3.35%
FCF(TTM)5.91
FCFY0.75%
OCF(TTM)14.74
OCFY1.87%
SpS54.53
BVpS21.83
TBVpS10.51
PEG (NY)0.55
PEG (5Y)2.49
Graham Number96.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 7.28 |
F-Score7
WACC8.74%
ROIC/WACC3.3
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y74.46%
EPS Next 2Y52.91%
EPS Next 3Y41.49%
EPS Next 5Y30.19%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year36.71%
Revenue Next 2Y27.31%
Revenue Next 3Y23.26%
Revenue Next 5Y17.7%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y29.64%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / LLY.DE FAQ
What is the fundamental rating for LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
What is the valuation status for LLY stock?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
What is the profitability of LLY stock?
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
What is the financial health of ELI LILLY & CO (LLY.DE) stock?
The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.
What is the expected EPS growth for ELI LILLY & CO (LLY.DE) stock?
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 74.46% in the next year.